Bell Investment Advisors’s Acceleron Pharma XLRN Stock Holding History

Bell Investment Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4	Closed	-$1K	–	2010
2021 Q3	$1K	Buy	+4	New	+$523	﹤0.01%	1694

Bell Investment Advisors's XLRN Position: Q4 2021 in Review

Bell Investment Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 4 shares — an estimated $1K sold.

Bell Investment Advisors first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Bell Investment Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Bell Investment Advisors sold 4 Acceleron Pharma shares in Q4 2021, an estimated $1K.
Bell Investment Advisors first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Bell Investment Advisors's Acceleron Pharma position peaked at $1K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bell Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.